Skip to content
Screener

Dare Bioscience, Inc. DARE Q2 2026 earnings

Reported August 13, 2026 · After market close

Revenue$187.5KBeat by $185.9K
EPS-$0.20Beat by $0.10
Revenue estimate$1.7K
EPS estimate-$0.30

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$2.0M
EPS estimate-$0.14

FAQ

When did Dare Bioscience, Inc. report Q2 2026 earnings?
Dare Bioscience, Inc. (DARE) reported Q2 2026 earnings on August 13, 2026 after market close.
What were Dare Bioscience, Inc.'s Q2 2026 revenue and EPS?
Dare Bioscience, Inc. reported revenue of $187.5K and eps of $-0.20 for Q2 2026.
Did Dare Bioscience, Inc. beat estimates in Q2 2026?
Revenue beat the consensus estimate of $1.7K by $185.9K. EPS beat the consensus estimate of $-0.30 by $0.10.
How did Dare Bioscience, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 985.8% from -$21.2K a year earlier and eps grew 55.6% from $-0.45.
Where can I find Dare Bioscience, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-037737) and the 10-Q periodic report (0001401914-26-000043) directly on SEC EDGAR. The filing index links above go to sec.gov.